Literature DB >> 49925

Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis.

F J Seil, M E Smith, A L Leiman, J M Kelly.   

Abstract

Sensitization of Lewis rats with whole central nervous system tissue or with purified myelin induced both experimental allergic encephalomyelitis (EAE) and a serum factor which inhibited myelin formation in vitro. Sensitization with the encephalitogenic factor, myelin basic protein, induced EAE, but not the myelination inhibition factor. Sensitization with cerebroside induced neither EAE nor myelination inhibition factor. The serums from control animals without EAE as well as from animals sensitized with all of the above antigens blocked evoked electrical responses in vitro.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49925     DOI: 10.1126/science.49925

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord.

Authors:  C L Schauf; F A Davis; D A Sack; B J Reed; R L Kesler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

Review 2.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

3.  Multiple sclerosis: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases.

Authors:  J Ulrich; H Lardi
Journal:  J Neurol       Date:  1978-04-14       Impact factor: 4.849

4.  Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.

Authors:  Christina Elliott; Maren Lindner; Ariel Arthur; Kathryn Brennan; Sven Jarius; John Hussey; Andrew Chan; Anke Stroet; Tomas Olsson; Hugh Willison; Susan C Barnett; Edgar Meinl; Christopher Linington
Journal:  Brain       Date:  2012-05-04       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.